Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fixed and adjustable dose asthma action plans based on combination therapy: a pilot study.

Shaun Holt1, Simon Ryder-Lewis, Matthew Masoli

  • 1P3 Research, Bowen Hospital, Wellington, New Zealand. shaun@p3research.co.nz

Respirology (Carlton, Vic.)
|September 2, 2005
PubMed
Summary

This study found that Symbicort Turbuhaler, a combination of budesonide and formoterol, effectively manages asthma when used in either a fixed or adjustable dose within a self-management plan. Both approaches provided comparable asthma control.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Severe asthma and remission prospects in Europe (SHARP): insights from a multicentre observational study based on the European Severe Asthma Registry.

The Lancet. Respiratory medicine·2026
Same author

Diabetic neuropathy.

The Lancet. Neurology·2026
Same author

Gastrointestinal symptoms and the Mediterranean dietary pattern: secondary analysis of a randomized controlled trial in a population with increased cardiometabolic risk.

Frontiers in nutrition·2026
Same author

Unanswered questions regarding the AIR strategy in children - Authors' reply.

Lancet (London, England)·2026
Same author

Marine neurology.

The Lancet. Neurology·2026
Same author

Anti-Inflammatory Reliever Therapy in Asthma: A Review.

Journal of the Royal Society of New Zealand·2026

Area of Science:

  • Pulmonology
  • Respiratory Medicine
  • Pharmacology

Background:

  • Asthma management often involves inhaled corticosteroids and long-acting beta-agonists.
  • Self-management plans are crucial for effective asthma control.
  • The efficacy of combination therapy within self-management plans requires investigation.

Purpose of the Study:

  • To investigate the use of combination inhaled corticosteroid/long-acting beta-agonist therapy (Symbicort Turbuhaler) within a self-management plan.
  • To compare fixed versus adjustable dose regimens of Symbicort in adult asthmatic patients.
  • To evaluate asthma control and treatment outcomes.

Main Methods:

  • Randomized open-label study involving 69 adult asthmatic patients.
  • Patients previously on high-dose beclomethasone dipropionate (BDP) were treated with Symbicort Turbuhaler (200 microg budesonide/6 microg formoterol) for 3 months.

Related Experiment Videos

  • Participants were assigned to either a fixed or adjustable dose self-management plan, with episode-free days as the primary outcome.

    • Main Results:

    • Both fixed and adjustable dose regimens of Symbicort demonstrated good asthma control, comparable to previous high-dose inhaled corticosteroid therapy.
    • No significant differences in clinical outcomes were observed between the two self-management regimens.
    • Mean daily Symbicort usage was similar across both fixed (3.8 puffs) and adjustable (3.6 puffs) dose groups.

    Conclusions:

    • Symbicort Turbuhaler is effective when used as part of a self-management plan.
    • Both fixed and adjustable dose regimens are viable options for asthma self-management with Symbicort.
    • Combination therapy with Symbicort offers effective asthma control within a patient-centered approach.